Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stagezero Life Sciences Ltd (OP: SZLSF )

0.0458 +0.0442 (+2762.50%)
Streaming Delayed Price Updated: 3:18 PM EST, Dec 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stagezero Life Sciences Ltd

< Previous 1 2 Next >
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order
Via ACCESSWIRE
StageZero Life Sciences Announces Update on Filing of Full Year 2023 financials under the Failure to File Cease Trade Order
Via ACCESSWIRE
StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
Via ACCESSWIRE
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
Via ACCESSWIRE
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
Via ACCESSWIRE
StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings
Via ACCESSWIRE
StageZero Life Sciences’ Clinical Business Introduces Third Pillar to Cancer Offerings
Via ACCESSWIRE
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
Via ACCESSWIRE
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
Via ACCESSWIRE
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
Via ACCESSWIRE
StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023
Via ACCESSWIRE
StageZero Announces Solutions for Employers to Help Improve Cancer Outcomes
Via ACCESSWIRE
StageZero Life Sciences, Ltd Announces Q3 2022 Financial Results and Operational Update
Via ACCESSWIRE
StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022
Via ACCESSWIRE
StageZero Life Sciences, Ltd Announces Q2 2022 Financial Results and Operational Update
Via ACCESSWIRE
StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022
Via ACCESSWIRE
StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting
TORONTO, ON / ACCESSWIRE / June 28, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences Announces Resignation of CFO
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / May 26, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences Partners With DiagnoseAtHome To Offer Multi-Cancer Blood Test
StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) 
Via Benzinga
StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA
First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of blood 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / May 17, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare company devoted to improving the early... 
From StageZero Life Sciences Ltd
Via AccessWire
Exposures COVID-19
StageZero Life Sciences Launches COC Plus Worldwide
TORONTO, ON / ACCESSWIRE / May 15, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its first quarter financial results before the market... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences, Ltd Announces Corporate Update
TORONTO, ON / ACCESSWIRE / April 6, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), a vertically-integrated healthcare company devoted to improving the early detection and... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Update
TORONTO, ON / ACCESSWIRE / April 1, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), a vertically-integrated healthcare company devoted to improving the early detection and... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences Launches AVRT(TM) in the UK
Innovative program helps identify and address the early warning signs of cancer and chronic disease TORONTO, ON / ACCESSWIRE / March 31, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF)... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Friday April 1
TORONTO, ON / ACCESSWIRE / March 29, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its fourth quarter and year end 2021 operational... 
From StageZero Life Sciences Ltd
Via AccessWire
CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe
This release replaces and corrects the release that was issued earlier this morning TORONTO, ON / ACCESSWIRE / March 14, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) ("StageZero" or... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences Announces Availability of COC Protocol in Europe
TORONTO, ON / ACCESSWIRE / March 14, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the... 
From StageZero Life Sciences Ltd
Via AccessWire
StageZero Life Sciences Announces Warrant Extension
TORONTO, ON / ACCESSWIRE / February 4, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the... 
From StageZero Life Sciences Ltd
Via AccessWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.